These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6982915)

  • 1. Lymphocyte surface membrane immunoglobulin in myeloma. III. IgA plasmacytomas induce large numbers of circulating, adult-thymectomy-sensitive, theta +, Lyt-1-2+ lymphocytes with IgA-Fc receptors.
    Hoover RG; Dieckgraefe BK; Lake J; Kemp JD; Lynch RG
    J Immunol; 1982 Dec; 129(6):2329-31. PubMed ID: 6982915
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocyte surface membrane immunoglobulin in myeloma. II. T cells with IgA-Fc receptors are markedly increased in mice with IgA plasmacytomas.
    Hoover RG; Lynch RG
    J Immunol; 1980 Sep; 125(3):1280-8. PubMed ID: 6967897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased T gamma and T mu cells in BALB/c mice with IgG and IgM plasmacytomas and hybridomas.
    Mathur A; Lynch RG
    J Immunol; 1986 Jan; 136(2):521-5. PubMed ID: 2934474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells with FC receptors in myeloma; suppression of growth and secretion of MOPC-315 by T alpha cells.
    Müller S; Hoover RG
    J Immunol; 1985 Jan; 134(1):644-7. PubMed ID: 3871117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells with Fc receptors for IgA: induction of T alpha cells in vivo and in vitro by purified IgA.
    Hoover RG; Dieckgraefe BK; Lynch RG
    J Immunol; 1981 Oct; 127(4):1560-3. PubMed ID: 6974197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte surface membrane immunoglobulin in myeloma. I. M315-bearing T lymphocytes in mice with MOPC-315.
    Gebel HM; Hoover RG; Lynch RG
    J Immunol; 1979 Sep; 123(3):1110-6. PubMed ID: 313945
    [No Abstract]   [Full Text] [Related]  

  • 7. Expansion of Fc receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma.
    Hoover RG; Hickman S; Gebel HM; Rebbe N; Lynch RG
    J Clin Invest; 1981 Jan; 67(1):308-11. PubMed ID: 6969732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors for IgA on human lymphocytes. II. Organ distribution and relationships with other Fc receptor-bearing populations.
    Lydyard PM; Fanger MW
    Scand J Immunol; 1981 Nov; 14(5):509-14. PubMed ID: 6977825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte Fc receptors: the special case of T cells.
    Sandor M; Lynch RG
    Immunol Today; 1993 May; 14(5):227-31. PubMed ID: 8517922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of FcR alpha on murine lymphocytes by IgA in vitro.
    Yodoi J; Adachi M; Masuda T
    J Immunol; 1982 Feb; 128(2):888-94. PubMed ID: 6976386
    [No Abstract]   [Full Text] [Related]  

  • 11. T lymphocyte-mediated suppression of myeloma function in vitro. IV. Generation of effector suppressor cells specific for myeloma idiotypes.
    Abbas AK; Takaoki M; Greene MI
    J Exp Med; 1982 Apr; 155(4):1216-21. PubMed ID: 6174675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative immunofluorescent analysis of surface phenotypes of murine B cell lymphomas and plasmacytomas with monoclonal antibodies.
    Lanier LL; Warner NL; Ledbetter JA; Herzenberg LA
    J Immunol; 1981 Oct; 127(4):1691-7. PubMed ID: 7024413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental regulation of immunoglobulin synthesis and secretion in plasmacytoma and hybridoma cells.
    Lynch RG; Mathur A; Van Ness B
    Monogr Allergy; 1987; 22():204-11. PubMed ID: 3501834
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a functional T-cell population by the use of surface markers: present limitations and new strategies.
    Mingari MC; Moretta A; Pantaleo G; Moretta L
    Ann Immunol (Paris); 1982; 133D(2):147-53. PubMed ID: 6819808
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased circulating T alpha lymphocyte population in bronchogenic and colonic carcinoma.
    Pucci A; Clancy RL; Doe WF
    Clin Exp Immunol; 1981 Oct; 46(1):130-3. PubMed ID: 6978211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface markers, antigens, and receptors on murine T and B cells: Part 3.
    Ahmed A; Smith AH
    Crit Rev Immunol; 1983; 4(2):95-128. PubMed ID: 6303691
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoclonal antibody (G6) inhibiting IgA binding to fixed Fc alpha R(+) T2D4 cells. Monoclonal antibody recognizing IgA-binding sites on fixed T2D4 cells.
    Tokumoto H; Shimada T; Doi T; Takeuchi E; Kawabe T; Yoshida H; Yodoi J
    Monogr Allergy; 1988; 24():208-14. PubMed ID: 3258954
    [No Abstract]   [Full Text] [Related]  

  • 18. Isotype-specific interactions between regulatory T cells and secreted and membrane-bound monoclonal immunoglobulins.
    Lynch RG; Mathur A; Williams KR; Mueller A
    Curr Top Microbiol Immunol; 1985; 122():200-4. PubMed ID: 3930151
    [No Abstract]   [Full Text] [Related]  

  • 19. Isotype-specific recognition and regulation by T cells studied with tumor models.
    Waldschmidt TJ; Williams KR; Lynch RG
    Int Rev Immunol; 1987 Jan; 2(2):203-20. PubMed ID: 2976804
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.